Anti-methicillin-resistant Staphylococcus aureus (Anti-MRSA) flavonoids from Iraqi Citrus sinensis (L.) Osbeck

Al-Majmaie, S, Nahar, L, Rahman, MM, Sharples, GP orcid iconORCID: 0000-0003-0492-0253, Arabnozari, H and Sarker, SD orcid iconORCID: 0000-0003-4038-0514 (2026) Anti-methicillin-resistant Staphylococcus aureus (Anti-MRSA) flavonoids from Iraqi Citrus sinensis (L.) Osbeck. Scientific Reports. ISSN 2045-2322

[thumbnail of Anti-methicillin-resistant Staphylococcus aureus (Anti-MRSA) flavonoids from Iraqi Citrus sinensis (L.) Osbeck.pdf]
Preview
Text
Anti-methicillin-resistant Staphylococcus aureus (Anti-MRSA) flavonoids from Iraqi Citrus sinensis (L.) Osbeck.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (1MB) | Preview

Abstract

Citrus sinensis (L.) Osbeck (Rutaceae) was investigated as a potential source of anti-MRSA compounds. A bioassay-guided isolation approach afforded fourteen compounds from the peel and leaf extracts of C. sinensis, including a new flavanone glycoside, sinensidin (10). Structural elucidation was based on spectroscopic analyses, including 1D and 2D NMR and HRMS data. Among the isolated compounds, 3-methoxynobiletin (4), sinensetin (7), and rutin 3′-methyl ether (12) exhibited moderate anti-MRSA activity (MIC = 128–256 µg/mL). The crude extract showed higher apparent activity than the individual compounds, suggesting possible contributions from additional constituents and/or synergistic interactions. This study expands the phytochemical profile of C. sinensis and suggests that its polymethoxylated flavonoids and flavonoid glycosides may contribute to anti-MRSA activity.

Item Type: Article
Uncontrolled Keywords: 30 Agricultural, Veterinary and Food Sciences; 32 Biomedical and Clinical Sciences; 3006 Food Sciences; Emerging Infectious Diseases; Dietary Supplements; Complementary and Integrative Health; Antimicrobial Resistance; Infectious Diseases
Subjects: R Medicine > RM Therapeutics. Pharmacology
R Medicine > RS Pharmacy and materia medica
Divisions: Pharmacy and Biomolecular Sciences
Publisher: Nature
Date of acceptance: 31 August 2026
Date of first compliant Open Access: 5 October 2026
Date Deposited: 05 Oct 2026 13:33
Last Modified: 05 Oct 2026 13:33
DOI or ID number: 10.1038/s41598-026-69806-7
URI: https://researchonline.ljmu.ac.uk/id/eprint/29604
View Item View Item